GXP PHARMAID ApS Financials, key figures and credit report
Gross profit 1 163.3 kDKK FY 2025 -13.2% vs 2024
EBIT 297.1 kDKK FY 2025 -40.2% vs 2024
Net debt - 320.6 kDKK FY 2025 +47.5% vs 2024
Quick ratio 3.0 FY 2025 +0.5 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 363.32 | 349.68 | 1 192.15 | 1 340.83 | 1 163.26 |
| Employee benefit expenses | - 989.95 | - 734.50 | - 517.15 | - 844.00 | - 866.12 |
| Total depreciation | -15.02 | -9.91 | |||
| EBIT | - 641.65 | - 394.72 | 675.01 | 496.82 | 297.14 |
| Other financial income | 9.11 | 5.82 | 6.00 | 6.31 | 13.57 |
| Other financial expenses | -11.30 | -21.57 | -22.45 | - 165.80 | - 119.75 |
| Pre-tax profit | - 643.84 | - 410.47 | 658.55 | 337.33 | 190.96 |
| Income taxes | 139.88 | 85.70 | - 145.39 | - 120.80 | -68.64 |
| Net earnings | - 503.96 | - 324.77 | 513.16 | 216.53 | 122.32 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 9.91 | ||||
| Tangible assets total | 9.91 | ||||
| Investments total | 14.75 | 15.60 | |||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 142.07 | 780.09 | 635.87 | 760.10 | 1 230.28 |
| Current amounts owed by group member comp. | 191.37 | 197.19 | 203.19 | 71.17 | |
| Current other receivables | 83.81 | ||||
| Current deferred tax assets | 139.88 | 225.58 | 80.19 | ||
| Short term receivables total | 557.13 | 1 202.86 | 919.25 | 831.27 | 1 230.28 |
| Cash and bank deposits | 449.07 | 27.97 | 763.19 | 970.85 | 596.41 |
| Cash and cash equivalents | 449.07 | 27.97 | 763.19 | 970.85 | 596.41 |
| Balance sheet total (assets) | 1 030.86 | 1 246.43 | 1 682.44 | 1 802.12 | 1 826.69 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Share premium account | 1 192.13 | ||||
| Retained earnings | - 121.88 | 566.29 | 241.52 | 754.68 | 971.21 |
| Profit of the financial year | - 503.96 | - 324.77 | 513.16 | 216.53 | 122.32 |
| Shareholders equity total | 691.29 | 366.52 | 879.68 | 1 096.21 | 1 218.53 |
| Non-current liabilities total | |||||
| Current trade creditors | 38.06 | 37.69 | 25.00 | 25.00 | 25.00 |
| Current owed to participating | 4.21 | 6.84 | 7.65 | 8.38 | 11.16 |
| Current owed to group member | 121.32 | 688.93 | 504.75 | 351.73 | 264.65 |
| Short-term deferred tax liabilities | 40.61 | 68.64 | |||
| Other non-interest bearing current liabilities | 175.99 | 146.46 | 265.37 | 280.20 | 238.70 |
| Current liabilities total | 339.57 | 879.92 | 802.76 | 705.91 | 608.16 |
| Balance sheet total (liabilities) | 1 030.86 | 1 246.43 | 1 682.44 | 1 802.12 | 1 826.69 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated